Brokerages Set UnitedHealth Group Incorporated (UNH) PT at $201.71
UnitedHealth Group Incorporated (NYSE:UNH) has earned an average rating of “Buy” from the twenty-six research firms that are covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold rating and twenty-three have given a buy rating to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $201.71.
A number of equities analysts recently issued reports on the company. Cowen and Company reaffirmed an “outperform” rating and issued a $220.00 price target (up from $175.00) on shares of UnitedHealth Group in a report on Friday, August 11th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Morgan Stanley upped their price target on UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a report on Thursday, August 17th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Jefferies Group LLC reaffirmed a “buy” rating and issued a $215.00 price target on shares of UnitedHealth Group in a report on Friday, August 18th.
Shares of UnitedHealth Group (NYSE:UNH) traded down 1.29% during trading on Friday, hitting $197.90. 4,068,977 shares of the company traded hands. UnitedHealth Group has a 52-week low of $133.03 and a 52-week high of $200.76. The stock has a market capitalization of $191.34 billion, a PE ratio of 23.77 and a beta of 0.63. The company has a 50-day moving average of $196.20 and a 200-day moving average of $183.34.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period in the prior year, the company posted $1.96 earnings per share. Equities analysts expect that UnitedHealth Group will post $9.87 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Investors of record on Friday, September 8th were issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date was Thursday, September 7th. UnitedHealth Group’s dividend payout ratio is presently 35.13%.
WARNING: “Brokerages Set UnitedHealth Group Incorporated (UNH) PT at $201.71” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another site, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The original version of this piece can be read at https://www.thecerbatgem.com/2017/10/05/brokerages-set-unitedhealth-group-incorporated-unh-pt-at-201-71.html.
In related news, Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction on Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the transaction, the director now owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Larry C. Renfro sold 50,574 shares of the company’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the transaction, the insider now directly owns 195,625 shares in the company, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. Insiders have sold 76,174 shares of company stock worth $14,981,909 in the last ninety days. 0.89% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently made changes to their positions in the stock. Regal Wealth Group Inc. grew its holdings in UnitedHealth Group by 0.4% during the second quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock worth $138,000 after acquiring an additional 3 shares during the period. Jackson Grant Investment Advisers Inc. grew its holdings in UnitedHealth Group by 0.4% during the first quarter. Jackson Grant Investment Advisers Inc. now owns 1,097 shares of the healthcare conglomerate’s stock worth $180,000 after acquiring an additional 4 shares during the period. RB Capital Management LLC grew its holdings in UnitedHealth Group by 0.4% during the second quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $321,000 after acquiring an additional 7 shares during the period. Altfest L J & Co. Inc. grew its holdings in UnitedHealth Group by 0.3% during the second quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock worth $549,000 after acquiring an additional 10 shares during the period. Finally, Parkside Financial Bank & Trust grew its holdings in UnitedHealth Group by 1.4% during the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after acquiring an additional 12 shares during the period. 86.19% of the stock is currently owned by hedge funds and other institutional investors.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.